Back to GetFilings.com



Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 


 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2004

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to             

 

Commission File Number 0-20981

 


 

DOCUMENT SCIENCES CORPORATION

(Exact name of registrant as specified in its charter)

 


 

Delaware   33-0485994

(State or Other Jurisdiction of

Incorporation or Organization)

 

(IRS Employer

Identification No.)

 

6339 Paseo del Lago

Carlsbad, California 92009

(Address of Principal Executive Offices including Zip Code)

 

(760) 602-1400

(Registrant’s Telephone Number including Area Code)

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the Registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2)    Yes  ¨    No  x

 

As of November 12, 2004, there were 4,009,505 shares of common stock of the registrant outstanding.

 



Table of Contents

DOCUMENT SCIENCES CORPORATION

 

     Page
No.


PART I. FINANCIAL INFORMATION     

Item 1. Financial Statements (Unaudited)

    

Consolidated balance sheets

   3

Consolidated statements of operations

   4

Consolidated statements of cash flows

   5

Notes to consolidated financial statements

   6

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   9

Item 3. Quantitative and Qualitative Disclosures About Market Risk

   24

Item 4. Controls and Procedures

   24
PART II. OTHER INFORMATION     

Item 1. Legal Proceedings

   25

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

   25

Item 6. Exhibits

   25

Signatures

   27

 

2


Table of Contents

PART I. FINANCIAL INFORMATION

 

ITEM 1–FINANCIAL STATEMENTS (Unaudited)

 

DOCUMENT SCIENCES CORPORATION

CONSOLIDATED BALANCE SHEETS

 

     September 30,
2004


    December 31,
2003


 
     (Unaudited)     (See note
below)
 

ASSETS

                

Current assets:

                

Cash and cash equivalents

   $ 2,835,039     $ 1,916,595  

Short-term investments

     1,941,087       3,979,864  

Accounts receivable, net

     7,696,335       6,959,940  

Other current assets

     966,781       655,392  
    


 


Total current assets

     13,439,242       13,511,791  

Property and equipment, net

     625,254       689,575  

Software development costs, net

     3,496,399       2,494,634  

Goodwill, net

     4,495,192       724,615  

Other assets

     51,984       202,944  
    


 


Total assets

   $ 22,108,071     $ 17,623,559  
    


 


LIABILITIES AND STOCKHOLDERS’ EQUITY

                

Current liabilities:

                

Accounts payable

   $ 359,283     $ 205,036  

Accrued compensation

     1,488,644       1,088,772  

Other accrued liabilities

     737,223       1,159,686  

Deferred revenue

     10,763,761       10,356,855  
    


 


Total current liabilities

     13,348,911       12,810,349  

Obligations under capital leases

     53,548       69,405  

STOCKHOLDERS’ EQUITY

                

Common stock, $.001 par value

     4,136       3,331  

Treasury stock

     (472,231 )     (556,352 )

Additional paid-in capital

     12,173,375       8,759,120  

Accumulated comprehensive loss

     (108,829 )     (88,611 )

Retained deficit

     (2,890,839 )     (3,373,683 )
    


 


Total stockholders’ equity

     8,705,612       4,743,805  
    


 


Total liabilities and stockholders’ equity

   $ 22,108,071     $ 17,623,559  
    


 


 

Note: The balance sheet at December 31, 2003 has been derived from the audited consolidated financial statements at that date but does not include all of the information and disclosures required by generally accepted accounting principles for complete financial statements. See notes to unaudited consolidated financial statements.

 

3


Table of Contents

DOCUMENT SCIENCES CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

    

Three Months Ended

September 30,


   

Nine Months Ended

September 30,


 
     2004

   2003

    2004

   2003

 

Revenues:

                              

Initial license fees

   $ 1,908,337    $ 1,010,677     $ 5,109,358    $ 3,516,170  

Annual renewal license and support fees

     2,952,828      2,660,336       8,690,972      7,853,812  

Services and other

     1,174,813      909,558       2,973,905      2,940,443  
    

  


 

  


Total revenues

     6,035,978      4,580,571       16,774,235      14,310,425  

Cost of revenues:

                              

Initial license fees

     493,645      286,043       1,027,744      786,524  

Annual renewal license and support fees

     455,835      444,889       1,473,588      1,264,100  

Services and other

     941,975      700,474       2,373,340      2,101,459  
    

  


 

  


Total cost of revenues

     1,891,455      1,431,406       4,874,672      4,152,083  
    

  


 

  


Gross margin

     4,144,523      3,149,165       11,899,563      10,158,342  

Operating expenses:

                              

Research and development

     957,725      873,259       2,789,432      3,549,245  

Selling and marketing

     2,229,625      1,837,325       6,212,809      6,612,282  

General and administrative

     765,289      688,127       2,450,393      2,070,853  
    

  


 

  


Total operating expenses

     3,952,639      3,398,711       11,452,634      12,232,380  
    

  


 

  


Income (loss) from operations

     191,884      (249,546 )     446,929      (2,074,038 )

Interest and other income (loss) , net

     13,577      (80,627 )     55,037      28,140  
    

  


 

  


Income (loss) before income taxes

     205,461      (330,173 )     501,966      (2,045,898 )

Provision for income taxes

     —        11,007       19,123      37,451  
    

  


 

  


Net income (loss)

   $ 205,461    $ (341,180 )   $ 482,843    $ (2,083,349 )
    

  


 

  


Net income (loss) per share–basic

   $ 0.05    $ (0.09 )   $ 0.14    $ (0.54 )
    

  


 

  


Weighted average shares used in basic calculation

     3,952,686      3,900,727       3,486,379      3,883,538  
    

  


 

  


Net income (loss) per share–diluted

   $ 0.04    $ (0.09 )   $ 0.10    $ (0.54 )
    

  


 

  


Weighted average shares used in diluted calculation

     5,044,337      3,900,727       4,635,532      3,883,538  
    

  


 

  


 

See notes to unaudited consolidated financial statements.

 

4


Table of Contents

DOCUMENT SCIENCES CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

     Nine Months Ended
September 30,


 
     2004

    2003

 

Operating activities

                

Net income (loss)

   $ 482,843     $ (2,083,349 )

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

                

Depreciation and amortization

     245,420       322,495  

Loss on disposal of fixed assets

     —         124,425  

Amortization of software development costs

     730,093       487,778  

Provision for doubtful accounts

     (164,222 )     26,023  

Changes in operating assets and liabilities:

                

Accounts receivable

     (567,579 )     2,871,174  

Other assets

     (310,050 )     84,970  

Accounts payable

     154,262       31,390  

Accrued compensation

     399,869       (666,469 )

Other accrued liabilities

     (434,552 )     (59,332 )

Deferred revenue

     406,750       215,796  
    


 


Net cash provided by operating activities

     942,834       1,354,901  

Investing activities

                

Purchases of short-term investments

     (904,820 )     (3,103,269 )

Maturities of short-term investments

     2,935,000       3,190,000  

Purchases of property and equipment, net

     (181,054 )     (300,801 )

Proceeds from disposal of assets

     —         1,160  

Additions to software development costs

     (1,731,858 )     (1,191,200 )
    


 


Net cash provided by (used in) investing activities

     117,268       (1,404,110 )

Financing activities

                

Principal payments under capital lease obligations

     (15,857 )     (12,145 )

Purchase of Objectiva Software Solutions

     (392,844 )     —    

Purchase of treasury stock

     —         (11,390 )

Sale of treasury stock

     72,734       —    

Issuance of common stock

     209,464       107,202  
    


 


Net cash provided by (used in) financing activities

     (126,503 )     83,667  
    


 


Increase in cash and cash equivalents

     933,599       34,458  

Effect of foreign currency on cash

     (15,155 )     35,517  

Cash and cash equivalents at beginning of period

     1,916,595       2,284,367  
    


 


Cash and cash equivalents at end of period

   $ 2,835,039     $ 2,354,342  
    


 


Supplemental disclosure of cash flow information:

                

Interest paid

   $ 2,079     $ —    
    


 


Income taxes paid

   $ 19,123     $ 37,451  
    


 


Capital lease obligations entered into for property and equipment

   $ —       $ 109,313  
    


 


Acquisition of business in exchange for common stock

   $ 3,216,983     $ —    
    


 


 

See notes to unaudited consolidated financial statements.

 

5


Table of Contents

DOCUMENT SCIENCES CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

September 30, 2004

 

Note A - Basis of Presentation

 

The accompanying unaudited consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, certain information and disclosures normally included in complete financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the statements include all adjustments necessary, which are of a normal and recurring nature, for the fair presentation of our financial position and of the results of operations and cash flows for the interim periods presented.

 

These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2003, included in Document Sciences Corporation’s Annual Report on Form 10-K filed with the Securities and Exchange Commission. Operating results for the three and nine months ended September 30, 2004 are not necessarily indicative of the results that may be expected for any other interim period or for the year ending December 31, 2004. The consolidated balance sheet at December 31, 2003 has been derived from the audited financial statements at that date but does not include all of the information and disclosures required by accounting principles generally accepted in the United States for complete financial statements. Certain amounts for 2003 have been reclassified to conform with the 2004 presentation, including reclassification of $1,648,851 from “due from affiliates” to “accounts receivable” in the consolidated balance sheet at December 31, 2003.

 

Note B - Revenue Recognition

 

We recognize revenue in accordance with Statement of Position (SOP) 97-2, Software Revenue Recognition, Staff Accounting Bulletin (SAB) No. 101, Revenue Recognition in Financial Statements and SAB No. 104, Revenue Recognition. Initial license fees are recognized when a contract exists, the fee is fixed and determinable, software delivery has occurred and collection of the receivable is deemed probable. We use the residual method to recognize revenue for all of our license models. Our contracts specifically state the amount of initial and annual license fees due for each type of software licensed. If an undelivered element of the arrangement exists under the license arrangement, revenue is deferred based on vendor-specific objective evidence of the fair value of the undelivered element. If vendor-specific objective evidence of fair value does not exist for all undelivered elements, all revenue is deferred until sufficient evidence exists or all elements have been delivered. We recognize revenue on transactions with payment terms greater than 30 days but less than twelve months from the contract date, if we have a history of successfully collecting from the specific customer without providing concessions. Amounts billed or payments received in advance of revenue recognition are recorded as deferred revenue.

 

6


Table of Contents

Note C - Transactions with Affiliates

 

From April 2001 through November 2003, Xerox Corporation was an affiliate of Document Sciences. On November 18, 2003, we repurchased the remaining 740,024 shares of Document Sciences common stock owned by Xerox. Since that transaction, Xerox is no longer an affiliate.

 

Note D - Computation of Net Income (Loss) Per Share

 

We present our earnings (loss) per share (EPS) information in accordance with Statement of Financial Accounting Standards (SFAS) No. 128, Earnings per Share. Basic EPS is computed by dividing income or loss available to common stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Shares issued during the period and shares reacquired during the period are weighted for the portion of the period that they were outstanding. Basic EPS excludes any dilutive effects of options, warrants and convertible securities.

 

The computation of diluted EPS is similar to the computation of basic EPS, except that the denominator is increased to include the number of additional common shares that would have been outstanding if the common shares underlying outstanding options and warrants had been issued. The dilutive effect of outstanding options and warrants has been reflected in EPS by application of the treasury stock method. The treasury stock method recognizes the use of proceeds that could be obtained upon exercise of options and warrants in computing diluted EPS. It assumes that any proceeds would be used to purchase common stock at the average market price during the period. Options and warrants will have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options or warrants. Common stock options to purchase 267,844 and 67,301 shares were excluded from the calculation of weighted-average shares used in determining diluted EPS for the three months ended September 30, 2004 and 2003, respectively, and 138,357 and 45,871 shares were excluded for the nine months ended September 30, 2004 and 2003, respectively, as their effect would have been antidilutive.

 

The following table reconciles the shares used in computing basic and diluted EPS for the periods indicated:

 

     Three Months Ended

   Nine Months Ended

     September 30,
2004


   September 30,
2003


   September 30,
2004


   September 30,
2003


Weighted average common shares outstanding used in basic EPS calculation

   3,952,686    3,900,727    3,486,379    3,883,538

Effect of dilutive stock options

   1,091,651    —      1,149,153    —  
    
  
  
  

Shares used in diluted EPS calculation

   5,044,337    3,900,727    4,635,532    3,883,538
    
  
  
  

 

Note E - Stock-Based Compensation

 

As permitted by SFAS No. 123, Accounting for Stock-based Compensation, we have elected to follow Accounting Principles Board (APB) Opinion No. 25, Accounting for Stock Issued to Employees, and related interpretations in accounting for our employee stock options. Under APB Opinion No. 25, among other things, when the exercise price of our employee stock options is not less than the market price of the underlying stock on the date of grant, no compensation expense is recognized.

 

As required under SFAS No. 123, the pro forma effects of stock-based compensation on net income (loss) and net earnings (loss) per common share have been estimated at the date of grant using the Black-Scholes option pricing model based on the following weighted-average assumptions: risk-free interest rates of 4%, dividend yields of 0%, expected volatility of 55% to 109% and a weighted-average expected life of the option of seven years.

 

7


Table of Contents

For purposes of adjusted pro forma disclosures, the estimated fair value of the options is amortized to expense over the option’s vesting period. The effect of applying SFAS No. 123 for purposes of providing pro forma disclosures is not likely to be representative of the effects on our operating results for future years because changes in the subjective input assumptions can materially affect future value estimates. Our pro forma information is as follows:

 

     Three Months Ended

    Nine Months Ended

 
     September 30,
2004


    September 30,
2003


    September 30,
2004


    September 30,
2003


 

Net income (loss), as reported

   $ 205,461     $ (341,180 )   $ 482,843     $ (2,083,349 )

Less stock-based compensation expense

     (206,273 )     (183,526 )     (449,994 )     (503,946 )
    


 


 


 


Net income (loss), as reported less stock-

based compensation expense

   $ (812 )   $ (524,706 )   $ 32,849     $ (2,587,295 )
    


 


 


 


Adjusted pro forma basic net income (loss) per share

   $ 0.00     $ (0.13 )   $ 0.01     $ (0.67 )

Adjusted pro forma diluted net income (loss) per share

   $ 0.00     $ (0.13 )   $ 0.01     $ (0.67 )

 

Note F - Business Combination

 

On July 20, 2004, we completed the acquisition of the remaining 79% of the outstanding common stock of Objectiva Software Solutions, Inc. (Objectiva), which upon completion of the acquisition became our wholly-owned subsidiary. Objectiva is a services company specializing in enterprise software development, including rapid prototyping, product co-development, product migration, product porting and product reengineering. The acquisition was consummated pursuant to that certain Stock Purchase Agreement, dated as of June 27, 2004, by and among Document Sciences and the selling stockholders identified therein.

 

The results of operations of Objectiva have been included in the accompanying consolidated financial statements from the date of acquisition and were accounted using the purchase method of accounting. The total cost of the acquisition and the subsequent allocation was as follows:

 

Total acquisition costs:

        

Issuance of 629,793 shares of DSC common stock (a)

   $ 3,216,983  

Cash paid at acquisition to Objectiva shareholders

     392,844  

Acquisition related expenses

     299,662  

Existing investment

     150,000  
    


     $ 4,059,489  
    


Allocated to assets and liabilities as follows:

        

Tangible assets acquired

   $ 539,108  

Assumed liabilities

     (250,196 )

Goodwill

     3,770,577  
    


     $ 4,059,489  
    



(a) Based on the market value of our stock 2 days prior, the day of and 2 days subsequent to the acquisition date of July 20, 2004.

 

8


Table of Contents

Pro Forma Information

 

The following unaudited pro forma condensed combined financial data for the three and nine months ended September 30, 2004 and 2003 was derived from our historical financial statements and the historical financial statements of Objectiva prior to the acquisition. The unaudited pro forma condensed combined financial data give effect to the acquisition of Objectiva as if it had occurred at the beginning of each period presented. The unaudited pro forma condensed combined financial data has been prepared for comparative purposes only and do not purport to be indicative of the results of operations that would have actually resulted had the acquisition been in effect as of the periods indicated, or of future results of operations. The unaudited pro forma results for the three and nine months ended September 30, 2004 and 2003 are as follows:

 

    

Three Months Ended

September 30,


   

Nine Months Ended

September 30,


 
     2004

    2003

    2004

   2003

 

Revenues

   $ 6,041,629     $ 4,858,507     $ 17,269,667    $ 14,880,722  

Net income (loss)

   $ (212,138 )   $ (290,605 )   $ 14,260    $ (2,052,448 )

Net income (loss) per share–basic

   $ (0.05 )   $ (0.07 )   $ 0.00    $ (0.53 )

Net income (loss) per share–diluted

   $ (0.05 )   $ (0.07 )   $ 0.00    $ (0.53 )

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

Critical Accounting Policies

 

Our discussion and analysis of the financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates and judgments, including those related to revenue recognition, computer software costs, allowance for doubtful accounts and valuation allowance for net deferred tax assets. We base our estimates on historical and anticipated results and trends and on assumptions that we believe are reasonable under the circumstances, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. By their nature, estimates are subject to an inherent degree of uncertainty. Actual results may differ from our estimates. We believe that the following critical accounting policies and assumptions may involve a higher degree of judgment and complexity than others.

 

Revenue Recognition. We recognize revenue in accordance with SOP 97-2, Software Revenue Recognition, SAB No. 101, Revenue Recognition in Financial Statements and SAB No. 104, Revenue Recognition. Initial license fees are recognized when a contract exists, the fee is fixed and determinable, software delivery has occurred and collection of the receivable is deemed probable. We use the residual method to recognize revenue for all of our license models. Our contracts specifically state the amount of initial and annual license fees due for each type of software licensed. If an undelivered element of the arrangement exists under the license arrangement, revenue is deferred based on vendor-specific objective evidence of the fair value of the undelivered element. If vendor-specific objective evidence of fair value does not exist for all undelivered elements, all revenue is deferred until sufficient evidence exists or all elements have been delivered. We recognize revenue on transactions with payment terms greater than 30

 

9


Table of Contents

days but less than twelve months from the contract date, if we have a history of successfully collecting from the specific customer without providing concessions. Amounts billed or payments received in advance of revenue recognition are recorded as deferred revenue.

 

Revenues generated from consulting services are recognized as the related services are performed and collectibility is deemed probable. However, when such consulting services are deemed to be essential to the functionality of the delivered software product, revenue from the entire arrangement is recognized on a percentage of completion method or not until the contract is completed in accordance with SOP 81-1, Accounting for Performance of Construction-Type and Certain Production-Type Contracts, and Accounting Research Bulletin (ARB) No. 45, Long-Term Construction-Type Contracts. We measure progress under the percentage of completion method, depending on how the contract language is written, either by using the percentage of total project hours completed or by the completion of phases in the consulting project. Because (i) the phases of our consulting projects are generally not of great duration (2-6 weeks on average) and (ii) we have a variety of projects progressing at the same time, we believe that there are very limited circumstances where materially different amounts would be reported under different conditions or using different assumptions.

 

Software Development Costs. In accordance with SFAS No. 86, Accounting for the Costs of Computer Software to be Sold, Leased or Otherwise Marketed, costs incurred in the research and development of new software products and significant enhancements to existing software products are expensed as incurred until technological feasibility of the product has been established. After technological feasibility has been established, direct production costs, including programming and testing, are capitalized until general release of the product.

 

Capitalized costs of software to be sold, licensed or otherwise marketed are amortized using the greater of the amount computed using the ratio of current period product revenues to estimated total product revenues or the straight-line method over the remaining estimated economic lives of the products. It is possible that estimated total product revenues, the estimated economic life of the product, or both, will be reduced in the future. As a result, the carrying amount of capitalized software costs may be reduced in the future, which could cause our operating results in future periods to be adversely affected.

 

Impairment of Goodwill. The value of our goodwill could be impacted by future adverse changes such as declines in our operating results or failure to meet the performance projections included in our forecasts of future operating results. We evaluate these assets on an annual basis or more frequently if indicators of impairment exist. In the process of our annual impairment review, we primarily use the income approach methodology of valuation that includes the discounted cash flow method as well as other generally accepted valuation methodologies to determine the fair value of our assets. Significant management judgment is required in the forecasts of future operating results that are used in the discounted cash flow method of valuation. The estimates we have used are consistent with the plans and estimates that we use to manage our business. It is possible, however, that the plans and estimates used may be incorrect. If our actual results, or the plans and estimates used in future impairment analyses, are lower than the original estimates used to assess the recoverability of these assets, we could incur impairment charges.

 

Allowance for Doubtful Accounts. We maintain an allowance for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required, which would result in an additional general and administrative expense in the period such determination is made. At the end of each reporting period, we perform a detailed review of outstanding balances by customer and invoice. We utilize statistical and account specific analysis to determine the adequacy of our reserve, as well as comparing balances to historical losses. If our assumptions or analysis are incorrect, our operating results for future periods may be adversely affected.

 

10


Table of Contents

Deferred Income Taxes. Deferred income taxes reflect the net effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. At December 31, 2003, we had net deferred tax assets of $2.7 million. Due to the uncertainty of realizing a portion of these net deferred tax assets, we have maintained a valuation allowance of $2.4 million for net deferred tax assets. Such uncertainty primarily relates to the potential for future taxable income as well as loss carryforwards and tax credits expiring in 2018 and 2012, respectively. In addition, pursuant to Sections 382 and 383 of the Internal Revenue Code, annual use of our net operating loss carryforwards may be limited in the event of a cumulative change in ownership of more than 50% within a three-year period. No valuation allowance has been recorded to offset the remaining $275,000 of net deferred tax assets as we have determined that it is more likely than not that these assets will be realized within the next fiscal period. We will continue to assess the likelihood of realization of such assets; however, if future events occur which do not make the realization of such assets more likely than not, we will record a valuation allowance against all or a portion of the remaining net deferred tax assets. Examples of future events that might occur which would make the realization of such assets not likely are unanticipated costs associated with the integration of Objectiva and a lack of taxable income resulting from poor operating results during 2005. At September 30, 2004, the net deferred tax assets of $275,000 remained unchanged.

 

Results of Operations for the Three and Nine Months Ended September 30, 2004 and 2003

 

The following table shows the components of revenues, cost of revenues, operating expenses and other items as a percentage of total revenues in our consolidated statements of operations for the periods indicated:

 

     Three Months Ended
September 30,


    Nine Months Ended
September 30,


 
     2004

    2003

    2004

    2003

 

Revenues:

                        

Initial license fees

   32  %   22  %   30  %   25  %

Annual renewal license and support fees

   49     58     52     55  

Services and other

   19     20     18     20  
    

 

 

 

Total revenues

   100     100     100     100  

Cost of revenues:

                        

Initial license fees

   8     6     6     5  

Annual renewal license and support fees

   7     10     9     9  

Services and other

   16     15     14     15  
    

 

 

 

Total cost of revenues

   31     31     29     29  
    

 

 

 

Gross profit

   69     69     71     71  

Operating expenses:

                        

Research and development

   16     19     17     25  

Selling and marketing

   37     40     37     46  

General and administrative

   13     15     14     15  
    

 

 

 

Total operating expenses

   66     74     68     86  
    

 

 

 

Income (loss) from operations

   3     (5 )   3     (15 )

Interest and other income (loss), net

   —       (2 )   —       —    
    

 

 

 

Income (loss) before income taxes

   3     (7 )   3     (15 )

Provision for income taxes

   —       —       —       —    
    

 

 

 

Net income (loss)

   %   (7  )%   %   (15  )%
    

 

 

 

 

11


Table of Contents

Revenues

 

Our revenues are divided into three categories based upon the sources from which they are derived: initial license fees, annual renewal license and support fees, and services and other revenues. The following discussion is separated into these categories. We sell our products principally through our direct sales force domestically and through distributors and Value Added Resellers (VARs) internationally.

 

The following table summarizes revenues (in thousands) and the percentage change over the same period of the prior year for the periods indicated:

 

     Three Months Ended
September 30,


   

Nine Months Ended

September 30,


 
     2004

         2003

         2004

         2003

      

Initial license fees

   $ 1,908    89 %   $ 1,011    (63 )%   $ 5,109    45 %   $ 3,516    (44 )%

Annual renewal license and support fees

     2,953    11       2,660    9       8,691    11       7,854    11  

Services and other

     1,175    29       910    10       2,974    1       2,940    (4 )
    

        

        

        

      

Total revenues

   $ 6,036    32 %   $ 4,581    (24 )%   $ 16,774    17 %   $ 14,310    (13 )%
    

        

        

        

      

 

Initial license fees. Initial license fees consist primarily of upfront license fees for the first year of use of our products.

 

The components of initial license fees (in thousands) of our product families consist of the following:

 

     Three Months Ended
September 30,


    Nine Months Ended
September 30,


     2004

   2003

    2004

   2003

Products:

                            

CompuSet

   $ 981    $ 385     $ 2,388    $ 1,683

Document Library Services

     203      (59 )     840      700

xPression

     724      685       1,881      1,133
    

  


 

  

Total initial license fees

   $ 1,908    $ 1,011     $ 5,109    $ 3,516
    

  


 

  

 

The increases in initial license fees for the three and nine months ended September 30, 2004 were due to higher sales in the United States and improved product sales of CompuSet and xPression.

 

Annual renewal license and support fees. Annual renewal license and support fees consist of license fees for the initial and continued use and support of our licensed products. The increases for the three and nine months ended September 30, 2004 were due to increases in our base of licensed software and in pricing increases.

 

Services and other. Services and other revenues consist of fees for consulting, application development and training services performed by us as well as miscellaneous other operational revenues. The increase for the three months ended September 30, 2004 was largely due to consulting revenue from our Objectiva subsidiary.

 

12


Table of Contents

Cost of Revenues

 

The following table summarizes cost of revenues (in thousands) and the percentage change over the same period of the prior year for the periods indicated:

 

     Three Months Ended
September 30,


   

Nine Months Ended

September 30,


 
     2004

         2003

         2004

         2003

      

Initial license fees

   $ 493    73 %   $ 286    (47 )%   $ 1,028    31 %   $ 787    (37 )%

Annual renewal license and support fees

     456    2       445    11       1,474    17       1,264    10  

Services and other

     942    34       700    13       2,373    13       2,101    7  
    

        

        

        

      

Total cost of revenues

   $ 1,891    32 %   $ 1,431    (8 )%   $ 4,875    17 %   $ 4,152    (5 )%
    

        

        

        

      

 

Cost of initial license fees. Cost of initial license fees includes amortization of previously capitalized software development costs, costs of third-party software, employment costs for distribution personnel and product packaging. The increases for the three and nine months ended September 30, 2004 were primarily due to increases in amortization of software development costs of $177,400 and $242,300, respectively, associated with our xPression technology.

 

Cost of annual renewal license and support fees. Costs of annual renewal license fees consist principally of employment-related costs for our technical support staff. The increases for the three and nine months ended September 30, 2004 were primarily due to an increase in staff to support xPression.

 

Cost of services and other. Costs of services and other consist principally of the employment-related costs of our consulting and training staff. The increases for the three and nine months ended September 30, 2004 were primarily due to increased personnel expenses from the consolidation of Objectiva.

 

Operating Expenses

 

The following table summarizes operating expenses (in thousands) and the percentage change over the same period of the prior year for the periods indicated:

 

     Three Months Ended
September 30,


   

Nine Months Ended

September 30,


 
     2004

         2003

         2004

         2003

      

Research and development

   $ 958    10 %   $ 873    (27 )%   $ 2,789    (21 )%   $ 3,549    (11 )%

Selling and marketing

     2,230    21       1,838    (9 )     6,213    (6 )     6,612    21  

General and administrative

     765    11       688    (1 )     2,450    18       2,071    (10 )
    

        

  

 

        

      

Total operating expenses

   $ 3,953    16 %   $ 3,399    (13 )%   $ 11,453    (6 )%   $ 12,232    4 %
    

        

  

 

        

      

 

Research and development. Research and development expenses consist primarily of the employment-related costs of personnel, as well as from outside service providers, associated with developing new products, enhancing existing products, testing software products and developing product documentation. We anticipate that we will continue to direct significant resources to the development and enhancement of our products.

 

13


Table of Contents
     Three Months Ended
September 30,


   

Nine Months Ended

September 30,


 
     2004

         2003

         2004

         2003

      

Research and development (net)

   $ 958    10 %   $ 873    (27 )%   $ 2,789    (21 )%   $ 3,549    (11 )%

Capitalized software development costs

     449    (25 )     601    (1 )     1,732    26       1,379    (1 )
    

        

        

        

      

Research and development (gross)

   $ 1,407    (5 )%   $ 1,474    (18 )%   $ 4,521    (8 )%   $ 4,928    (8 )%
    

        

        

        

      

 

Capitalized software development costs mainly include payroll related costs of our engineering resources, allocated facilities costs and consulting fees paid to Objectiva in relation to the development of xPression. The amount of software development costs to be capitalized in the future will depend on the establishment of technological feasibility of a product, the amount of resources used in the project after technological feasibility has been reached and its general release date. We anticipate releasing xPression 2.0 in November 2004. Accordingly, no additional costs will be capitalized related to this product

 

The decrease in capitalized software development costs for the three months ended September 30, 2004 was primarily due to decreased resources spent working on technologically feasible products. The increase in capitalized software development costs for the nine months ended September 30, 2004 was primarily due to the timing of technological feasibility and additional testing being performed on xPression 2.0.

 

The decrease in gross research and development expenses for the three months ended September 30, 2004 was primarily due to a decrease in the use of outside consultants of $345,100 offset by an increase in personnel costs of $141,600. The decrease in gross research and development expenses for the nine months ended September 30, 2004 was primarily due to a decrease in the use of outside consultants of $278,600 and allocated facility and communication costs of $53,300.

 

Selling and marketing. Selling and marketing expenses consist primarily of salaries, commissions, marketing programs and related costs for pre- and post-sales activity. The increase for the three months ended September 30, 2004 was primarily due to increases in personnel costs of $347,800 and outside consultants of $117,700. The decrease for the nine months ended September 30, 2004 was primarily due to decreases in travel and meeting expenses of $223,000 and trade shows and advertising of $180,200.

 

General and administrative. General and administrative expenses consist of employment-related costs for finance, administration and human resources, allowance for doubtful accounts and general corporate management expenses, including legal and audit fees. The increases for the three and nine months ended September 30, 2004 were primarily due to increases in personnel costs of $182,600 and $405,400, respectively, offset by a reversal of a collected receivable previously written off of $107,500 for the three months ended September 30, 2004. The increases in personnel costs were due to a reclassification in 2004 of certain personnel from other departments.

 

Other items

 

Interest and other income (loss), net. Interest and other income (loss), net is composed of interest income from cash and cash equivalents and short-term investments, offset by interest expense related to capital leases and losses on disposals of fixed assets. Interest and other income (loss), net was $13,600 and $(80,600) for the three months ended September 30, 2004 and 2003, respectively, and $55,000 and $37,500 for the nine months ended September 30, 2004 and 2003, respectively. The lower amounts for the three and nine months ended September 30, 2003 were the result of a loss on the disposal of fixed assets in the third quarter of 2003.

 

14


Table of Contents

Provision for income taxes. Provision for income taxes was $0 and $11,000 for the three months ended September 30, 2004 and 2003, respectively, and $19,100 and $37,500 for the nine months ended September 30, 2004 and 2003, respectively. These amounts were due to foreign taxes. For the nine months ended September 30, 2004, there has been no change to the net deferred tax assets of $275,000, so there is no provision. We will continue to assess the likelihood of realization of our net deferred tax assets. If future events occur that do not make the realization of such assets more likely than not, a valuation allowance will be established against all or a portion of the net deferred tax assets.

 

Liquidity and Capital Resources

 

Our sources of cash come mainly from operations and sales and maturities of short-term investments. Our main uses of cash are for payroll and outside consultants. Our main project underway is xPression 2.0. We currently anticipate releasing this major upgrade of our xPression software in November 2004. We do not use any equity-linked derivatives or stock as a form of liquidity to fund our operations. We currently do not have any debt from borrowed money.

 

We believe that our existing cash balances and anticipated cash flows from operations will be sufficient to meet our anticipated cash needs for working capital and capital expenditures at least through the next twelve months. In this regard, a portion of our cash could be used to acquire or invest in complementary businesses or products or to obtain the right to use complementary technologies.

 

At September 30, 2004, we had $4.8 million in cash, cash equivalents and short-term investments. This is a decrease of $1.1 million from December 31, 2003 and is primary due to a $736,400 increase in receivables, a net increase of $1.0 million in software development costs and a decrease of $422,500 in accrued liabilities offset by increases of $406,900 in deferred revenue, $399,900 in accrued compensation and cash used in acquisition of Objectiva. Our short-term investments are invested in U.S. government agency obligations.

 

As of September 30, 2004, we did not have any other relationships with unconsolidated entities or financial partners, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. As such, we are not materially exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in such relationships

 

We have no significant capital spending or purchase commitments other than normal purchase commitments and commitments under facilities and equipment leases. Lease commitments for the next five years are $214,078, $54,517, $55,528, $47,893 and $2,986, respectively.

 

Acquisition of Objectiva. On July 20, 2004, we paid consideration of approximately $3.6 million for the remaining 79% of the outstanding common stock of Objectiva Software Solutions, Inc. not already owned by Document Sciences. Objectiva employed nearly 90 people, primarily in China, and specialized in enterprise software development, including rapid prototyping, product co-development, product migration and porting and product reengineering. We have had a business relationship with Objectiva since 2001. On January 16, 2002, we entered into a two-year, $3.1 million development services agreement with Objectiva to help with our programming of xPression. In 2002 and 2003, we acquired approximately 21% of their common stock. On January 16, 2004, we signed another two-year development services agreement for $3.3 million. The three founders of Objectiva are now officers of Document Sciences.

 

15


Table of Contents

Trends and Factors That May Affect Future Operating Results

 

Our total revenues and operating results can vary, sometimes substantially, from quarter to quarter and are expected to vary significantly in the future. Our revenues and operating results are difficult to forecast. Future results will depend upon many factors, including the demand for our products, the level of product and price competition, the length of our sales cycle, the size and timing of individual license transactions, the delay or deferral of customer implementations, the budget cycles of our customers, our success in expanding our direct sales force and indirect distribution channels, the timing of new product introductions and product enhancements by us and our competitors, the mix of products and services sold, levels of international sales, our ability to successfully implement our operational, growth and other strategies, activities of, and acquisitions by, competitors, the timing of new hires, changes in foreign currency exchange rates, our ability to develop and market new products, controlling costs and general domestic and international economic conditions. In addition, our sales generally reflect a relatively high amount of revenue per order, and, therefore, the loss or delay of individual orders could have a significant impact on our revenues and quarterly operating results. In addition, a significant amount of our revenues occur predominantly in the third month of each fiscal quarter and tend to be concentrated in the latter half of that third month.

 

Our software products generally are shipped as orders are received. As a result, initial license fees in any quarter are substantially dependent on orders booked and shipped in that quarter. The timing of receipt of initial license fees is difficult to predict because of the length of our sales cycle. For Autograph products, our sales cycle is typically three to nine months from initial contact. For xPression products, our sales cycle is typically six months to over one year from initial contact. Because our operating expenses are based on anticipated revenue trends and because a high percentage of our expenses are relatively fixed, a delay in the recognition of revenue from a limited number of initial license transactions could cause significant variations in operating results from quarter to quarter and could result in losses. To the extent such expenses precede, and/or are not subsequently followed by, increased revenues, our operating results could be materially adversely affected.

 

Due to the foregoing factors, revenues and operating results for any quarter are subject to significant variation, and we believe that period-to-period comparisons are not necessarily meaningful and should not be relied upon as indications of future performance.

 

Forward-looking Statements

 

We make forward-looking statements in this quarterly report on Form 10-Q that are subject to risks and uncertainties. These forward-looking statements include information about possible or assumed future results of our financial condition, operations, plans, objectives and performance. When we use the words “believe,” “expect,” “anticipate,” “estimate” or similar expressions, we are making forward-looking statements. Many possible events or factors could affect our future financial results and performance. This could cause our results or performance to differ materially from those expressed in our forward-looking statements. You should consider these risks when you review this document, along with the following possible events or factors:

 

  national, international, regional and local economic, competitive, geopolitical and regulatory conditions and developments;

 

16


Table of Contents
  the market for document automation software (including the emerging content processing market);

 

  market acceptance of enhancements to our existing products and introduction of new products;

 

  continued profitability of our professional services;

 

  maintaining our relationships with Xerox and our other distribution partners; and

 

  other uncertainties, all of which are difficult to predict and many of which are beyond our control.

 

Our actual results could differ materially from those discussed herein due to a number of factors, including those set forth in this discussion, under “Certain Factors Affecting Document Sciences Corporation” and other risks detailed from time to time in our SEC reports. In addition, the discussion of our results of operations should be read in conjunction with the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our 2003 Annual Report on Form 10-K for the fiscal year ended December 31, 2003 and in reports we file with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date of that statement. We undertake no obligation to publicly release the results of any revision of the forward-looking statements.

 

Certain Factors Affecting Document Sciences Corporation

 

The following is a discussion of certain factors that currently impact or may impact our business, operating results and/or financial condition. Anyone making an investment decision with respect to our common stock or other securities is cautioned to carefully consider these factors. If any of the following risks actually occur, our business, results of future operations and financial condition could be materially adversely affected. In such case, the trading price of our common stock could decline and you may lose part or all of your investment.

 

Our quarterly results fluctuate significantly and we may not be able to grow our business.

 

Our total revenues and operating results can vary, sometimes substantially, from quarter to quarter, and we expect them to vary significantly in the future. Additionally, our revenues and operating results are difficult to forecast, and our future results will depend upon many factors, including the following:

 

  the demand for our products;

 

  the level of product and price competition;

 

  the length of our sales cycle;

 

  the size and timing of individual license transactions;

 

  the delay or deferral of customer implementations;

 

  the budget cycles of our customers;

 

  our success in expanding our direct sales force or indirect distribution channels;

 

  the acceptance and timing of our new product introductions and enhancements, as well as those of our competitors;

 

17


Table of Contents
  our mix of products and services;

 

  our level of international sales;

 

  our ability to successfully implement our operational, growth and other strategies;

 

  the activities of, and acquisitions by, our competitors;

 

  our timing of new hires;

 

  changes in foreign currency exchange rates; and

 

  our ability to develop and market new products and to control costs.

 

Our initial license fee revenues mainly depend on when orders are received and shipped. However, because of our sales model, our customers’ implementation schedule and the complexity of the implementation process, revenue from some software shipments may not be recognized in the same quarter as the shipment occurs. Our operating expenses are primarily based on anticipated revenue levels. Since a high percentage of those expenses are relatively fixed, a delay in the recognition of revenue from license transactions could cause significant variations in operating results from quarter to quarter, and we may sustain losses as a result. To the extent such expenses precede, and/or are not subsequently followed by, increased revenues, our operating results could be materially adversely affected.

 

As a result of these factors, results from operations for any quarter are subject to significant variation, and we believe that period-to-period comparisons of our results of operations are not necessarily meaningful. Accordingly, you should not rely upon them as an indication of our future performance. Furthermore, our operating results in future quarters may fall below the expectations of market analysts and investors. If this occurs, the price of our common stock would likely be materially adversely affected.

 

Our growth depends on market acceptance of our existing products and our introduction of new products and enhancements to existing products.

 

Our future business, operating results and financial condition depends upon market acceptance of our existing products, as well as our ability to respond to emerging industry standards and practices and to develop new products that address the future needs of our target markets. Our Autograph family of products has been applied mainly to document automation applications producing paper-based documents. We have started to extend our core technology to the Internet, intranets and commercial on-line services. However, we cannot assure you that we will be successful in developing, introducing and marketing new products or product enhancements, including new products or the extension of existing products for the Internet, intranets and commercial on-line services, on a timely and cost effective basis, if at all. In addition, we cannot assure you that our newer products, such as xPression, or enhancements to existing products will adequately meet the requirements of the marketplace or achieve market acceptance. Moreover, delays in our commercial shipments of new products or enhancements may result in client dissatisfaction and a delay or loss of product revenues.

 

If for technological or other reasons we are unable to develop and introduce new products or enhancements of existing products in a timely manner in response to changing market conditions or client requirements, then our business, operating results and financial condition will be materially adversely affected. In addition, we cannot assure you that our existing products, new products or new versions of our existing products will achieve market acceptance. In order to provide our customers with integrated product solutions, our future success will also depend in part upon our ability to maintain and enhance relationships with our technology partners.

 

18


Table of Contents

Longer than expected sales cycles and implementation periods have affected and may continue to affect our revenues and operating results.

 

The licensing of our software products is often an enterprise-wide decision by prospective customers and generally involves a sales cycle of three months to more than one year in order to educate our prospective customers regarding the use and benefits of our products. In addition, the implementation of our products by customers involves a significant commitment of their resources over an extended period of time and is commonly associated with substantial customer business process reengineering efforts. Sales of our enterprise-wide xPression product line often involve many participants in the corporate decision-making process. Additionally, we have experienced and may, from time to time, continue to experience defects in our software which cause implementation problems and affect our sales and our sales cycle. For these and other reasons, our sales cycles and customer implementation periods are subject to a number of significant delays over which we have little or no control. Any delay in the sale or customer implementation of a limited number of license transactions could have a material adverse effect on our business and results of operations and cause our operating results to vary significantly from quarter to quarter.

 

We currently derive a significant portion of our revenues with Xerox.

 

We currently have a variety of contractual and informal relationships with Xerox and affiliates of Xerox, including a cooperative marketing agreement, a transfer and license agreement and various distribution agreements. We rely on these relationships and agreements for a significant portion of our total revenues. Revenues derived from relationships with Xerox and affiliates of Xerox accounted for approximately $2.6 million and $3.3 million for the nine months ended September 30, 2004 and 2003, respectively, representing 15% and 23% of our total revenues, respectively.

 

In November 2003, we paid $2.7 million to Xerox to repurchase the remaining 740,024 shares of Document Sciences’ common stock owned by Xerox. Since Xerox no longer has an equity interest in us, there may be less incentive in continuing to do business with us at the same level. Though we intend to continue our existing relationships with Xerox, our strategy is to lessen our dependence on Xerox by increasing our non-Xerox revenue. However, there can be no assurance that we will be able to do so and, because of our current level of dependence on Xerox, there can be no assurance that our plans to become more independent will not adversely affect our business, results of operations and financial condition. Our failure to maintain these relationships or to establish new relationships in the future could have a material adverse effect on our business, operating results and financial condition.

 

There can be no assurance that existing and potential customers will continue to do business with us because of these relationships or our historical ties with Xerox and its affiliates. Xerox has strategic alliances and other business relationships with other companies who supply software and services used in high volume electronic publishing applications and who now are, or in the future may become, our competitors. There can be no assurance that Xerox or one of its affiliated companies will not engage in business that directly competes with us. In addition, Xerox has ongoing internal development activities that could lead to products that compete with us. Xerox could expand these relationships or enter into additional ones, and as a result our business could be materially adversely affected.

 

Our growth depends on our ability to compete successfully against current and future competitors.

 

The market for our document automation products is intensely competitive. We face competition from a broad range of competitors, many of whom have greater financial, technical, and marketing resources

 

19


Table of Contents

than we do. Our principal competition currently comes from systems developed in-house by the internal MIS departments of large organizations and direct competition from numerous software vendors, including Docucorp International, Inc., InSystems Technologies, Inc., Group 1 Software, Inc., Exstream Software, Inc. and Metavante Corporation. We believe that the principal competitive factors affecting our market include product performance and functionality, ease of use, scalability, operating across multiple computer and operating system platforms, product and company reputation, client service and support and price. Although we believe we currently compete favorably with respect to such factors, we can not assure you that we will be able to maintain our competitive position against current and future competitors, especially those with greater financial, technical and marketing resources than us, or that we will be successful in the face of increasing competition from new products, new solutions introduced by existing competitors or by new companies entering the market.

 

The success of our recent acquisition depends on successful integration.

 

We may not be able to successfully integrate Objectiva’s operations, personnel or products or we may incur unanticipated costs with the integration of Objectiva into Document Sciences. The acquisition of Objectiva could result in the diversion of capital and management’s attention away from other business issues and opportunities. In addition, our acquisition may not be successful in achieving our desired strategic objectives which could cause our business to suffer. If we fail to successfully integrate this acquisition, our business could be materially adversely affected.

 

Our operating results are substantially dependent on sales of a small number of products in highly concentrated industries.

 

For the nine months ended September 30, 2004, we had derived 47%, 16% and 37% of our initial license revenues from our CompuSet, DLS and xPression product lines, respectively. As a result, factors that may adversely impact the pricing of or demand for these products, such as competition from other products, negative publicity or obsolescence of the hardware or software environments in which our products run, could have a material adverse effect on our business, operating results and financial condition. Our financial performance will depend significantly on the successful development, introduction and customer acceptance of new and enhanced versions of our xPression software, as well as continued customer acceptance of CompuSet, DLS and related products.

 

Licenses to end users in the insurance and finance industries in the United States accounted for 66% and 22% of initial license revenues in 2004, respectively. Our future success will depend on our ability to continue to successfully market our products in these and other industries. Our failure to do so would have a material adverse effect on our business, operating results and financial condition.

 

Our growth is dependent upon successfully focusing our distribution channels.

 

To grow our business, we must streamline our worldwide sales and distribution channels by focusing on key target industry market segments where our current and planned products can enjoy a significant competitive advantage and high market demand. We also must leverage our existing relationships with Xerox and other partners by launching targeted joint marketing and value added reseller programs and by introducing new product offerings that are optimized for selected target markets and marketing channels. Additionally, we must form additional partnerships with system integrators and consultants in order to broaden our capacity to deliver complete document automation solutions that incorporate significant services content, while also maintaining our core domain expertise. We cannot assure you that we will be able to successfully streamline and focus our worldwide channels, leverage our existing relationships or form new alliances. If we fail to do so, it will have a material adverse effect on our business, operating results and financial condition.

 

20


Table of Contents

Our products may suffer from defects or errors.

 

Software products as complex as those we offer, may contain undetected defects or errors when first introduced or as new versions are released. As a result, we could in the future lose or delay recognition of revenues as a result of software errors or defects. In addition, our products are typically intended for use in applications that may be critical to a customer’s business. As a result, we expect that our customers and potential customers have a greater sensitivity to product defects than the general market for software products. We have experienced defects in connection with the introduction of our xPression product line and we have worked to address this problem, but we cannot assure you that, despite our testing as well as testing by current and potential customers, errors will not be found in our existing products or new products or releases. Defects discovered after the commencement of commercial shipments, can result in any of the following:

 

  loss of revenue

 

  delay in market acceptance;

 

  diversion of our development resources;

 

  damage to our reputation; or

 

  increased service and warranty costs.

 

Maintaining our professional services expertise is necessary for our future growth.

 

We are continuing our focus on the consulting services component of our professional services to assist customers in the planning and implementation of enterprise-wide, mission-critical document automation and content processing applications. This strategy is dependent on retaining and hiring professionals to perform these consulting services. Should we be unable to maintain the necessary services workforce, our business and financial condition could be materially adversely affected.

 

We may be exposed to risks associated with international operations.

 

Our revenues from export sales, including sales through our European subsidiary, accounted for $1.1 million and $1.3 million for the three months ended September 30, 2004 and 2003, respectively, and $3.6 million and $4.1 million for the nine months ended September 30, 2004 and 2003, respectively.

 

Our wholly owned subsidiary, Document Sciences Europe, markets and supports our products in Europe, Africa and the Middle East, for which they receive an agent fee. We license our products in Europe through VARs and to a much lesser extent, direct sales. Revenues generated by the activities of this subsidiary were $706,000 and $679,900 for the three months ended September 30, 2004 and 2003, respectively, and $2.3 million and $2.4 million for the nine months ended September 30, 2004 and 2003, respectively.

 

In Australia, Canada and Latin America, our products are distributed and/or supported by Xerox affiliates and also by direct sale in Canada. Revenues generated in these regions were $444,000 and $653,800 for the three months ended September 30, 2004 and 2003, respectively, and $1.3 million and $1.7 million for the nine months ended September 30, 2004 and 2003, respectively.

 

21


Table of Contents

In China, our products are distributed and/or supported by our subsidiary, Objectiva. Additionally, Objectiva generates revenues in China through consulting engagements. Revenues generated in China were $2,500 for the three months ended September 30, 2004.

 

In order to successfully expand export sales, we must establish additional foreign operations, hire additional personnel and develop relationships with additional international resellers. If we are unable to do so in a timely manner, our growth in international export sales could be limited, and our business, operating results and financial condition could be materially adversely affected. In addition, we cannot assure you that we will be able to maintain or increase international market demand for our products.

 

Additional risks inherent in our international business activities include:

 

  losing the services of our key resellers;

 

  difficulties in managing our international operations;

 

  lack of acceptance of our localized products in foreign countries;

 

  our limited experience in localizing products for foreign countries;

 

  longer accounts receivable payment cycles;

 

  currency fluctuations;

 

  unexpected changes in regulatory requirements;

 

  tariffs and other trade barriers;

 

  potentially adverse tax consequences including restrictions on the repatriation of earnings; and

 

  the burdens of complying with a wide variety of foreign laws.

 

A portion of our business is conducted in currencies other than the U.S. Dollar, primarily the Euro and the Chinese Yuan. Although exchange rate fluctuations have not had a significant impact on us, fluctuations in the value of the currencies in which we conduct our business relative to the U.S. Dollar could cause currency transaction gains and losses in future periods. We do not currently engage in currency hedging transactions, and we cannot assure you that fluctuations in currency exchange rates in the future will not have a material adverse impact on our international revenues and our business, operating results and financial condition.

 

Our business is dependent on the market for document automation and content processing software.

 

The market for document automation software is intensely competitive, highly fragmented and subject to rapid change. We cannot assure you that the market for document automation software will continue to grow or that, if it does grow, organizations will adopt our products. We have spent, and intend to continue to spend, significant resources educating potential customers about the benefits of our products. However, we cannot assure you that such expenditures will enable our products to achieve further market acceptance, and if the document automation software market develops more slowly than we currently anticipate, our business, operating results and financial condition would be materially adversely affected.

 

22


Table of Contents

In addition, the commercial market for content processing of electronic documents designed for use with the Internet, intranets and commercial on-line services has only recently begun to develop, and the success of our products designed for this market will depend in part on their compatibility with such services. It is difficult to predict whether the demand for related products and services would increase or decrease in the future. Since the increased commercial use of the Internet, intranets and commercial on-line services could require substantial modification and customization of certain of our products and services as well as the introduction of new products and services, we cannot assure you that we will be able to effectively or successfully compete in the future in this market.

 

Our ability to manage future change will affect our business.

 

Our ability to compete effectively and to manage future change will require us to continue to improve our financial and management controls, reporting systems and procedures on a timely basis and to expand, train and manage our work force. We cannot assure you that we will be able to do so successfully. Our failure to do so could have a material adverse effect on our business, operating results and financial condition.

 

Our executive officers and certain key personnel are critical to our business, and these officers and key personnel may not remain with us in the future.

 

Our future performance depends in significant part upon the continued service of our key technical, sales and senior management personnel. The loss of the services of one or more of our executive officers could have a material adverse effect on our business, operating results and financial condition. Our future success also depends on our continuing ability to attract and retain highly qualified product development, sales and management personnel. Competition for such personnel is intense, and there can be no assurance that we will be able to retain our key employees or that we will be able to attract or retain other highly qualified product development, sales and managerial personnel in the future.

 

Our business is dependent upon successfully protecting our proprietary rights.

 

We rely on a combination of copyright and trademark laws, trade secrets, confidentiality procedures and contractual provisions to protect our proprietary rights. Despite these precautions, it may be possible for unauthorized third parties to copy portions of our products or use information we consider proprietary. Policing unauthorized use of our products is difficult and, while we are unable to determine the extent to which piracy of our software products exists, we expect software piracy to be a persistent problem. In addition, the laws of some foreign countries do not protect our proprietary rights to as great an extent as do the laws of the United States. We cannot assure you that our means of protecting our proprietary rights will be adequate or that our competitors will not independently develop similar technology.

 

We are not aware of any infringement by our products upon the proprietary rights of third parties. However, we cannot assure you that third parties will not claim infringement by us with respect to current or future products. We expect that software product developers will increasingly be subject to infringement claims as the number of products and competitors in our industry segment grows and the functionality of products in different industry segments overlaps. Any such claims, with or without merit, could be time consuming, result in costly litigation, cause product shipment delays or require us to enter into royalty or licensing agreements. Such royalty or licensing agreements, if required, may not be available on terms acceptable to us or at all, which could have a material adverse effect upon our business, operating results and financial condition.

 

23


Table of Contents

Our failure to adequately limit our exposure to product liability claims may adversely affect us.

 

Our license agreements with our customers typically contain provisions designed to limit our exposure to potential product liability claims. However, it is possible that the limitation of liability provisions contained in our license agreements may not be effective under the laws of certain jurisdictions. Although we have not experienced any product liability claims to date, sale and support of our products may entail the risk of such claims in the future. A successful product liability claim brought against us or a claim arising as a result of our professional services could have a material adverse effect upon our business, operating results and financial condition.

 

If any of these factors occur, it could have a material adverse effect upon our business, operating results and financial condition.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Foreign Currency Exchange Risk

 

Our earnings and cash flows are subject to fluctuations due to changes in foreign currency exchange rates. To a certain extent, foreign currency exchange rate movements also affect our competitive position, as exchange rate changes may affect business practices and/or pricing strategies on non-U.S. based competitors. Our primary foreign currency risk exposure is related to U.S. Dollar to Euro conversions. Considering the anticipated cash flows from firm sales commitments and anticipated sales for the next quarter, a hypothetical 10% weakening or strengthening of the U.S. Dollar relative to all other currencies would not materially adversely affect expected fourth quarter 2004 earnings or cash flows. This analysis is dependent on actual export sales during the next quarter occurring within 90% of budgeted forecasts. The effect of the hypothetical change in exchange rates ignores the affect this movement may have on other variables including competitive risk. If it were possible to quantify this competitive impact, the results could well be different than the sensitivity effects described above. In addition, it is unlikely that all currencies would uniformly strengthen or weaken relative to the U.S. Dollar. In reality, some currencies may weaken while others may strengthen. Each month, we review our position for expected currency exchange rate movements.

 

Interest Rate Risk

 

We are exposed to changes in interest rates primarily from our short-term available-for-sale investments. Under our current policies, we do not use interest rate derivative instruments to manage exposure to interest rate changes. A hypothetical 100 basis point adverse move in interest rates along the entire interest rate yield curve would not materially affect the fair value of our interest sensitive financial instruments at September 30, 2004. Declines in interest rates over time will, however, reduce our interest income.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

As of the end of the period covered by this quarterly report on Form 10-Q, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures. That evaluation was performed under the supervision and with the participation of our management, including our Chief Executive Officer, who also serves as our Chief Financial Officer. Based on that evaluation, our Chief Executive Officer concluded that our disclosure controls and procedures are effective in timely alerting him to material information relating to Document Sciences required to be included in our periodic SEC filings.

 

24


Table of Contents

Changes in Internal Control over Financial Reporting

 

During the three months ended September 30, 2004, we completed our acquisition of Objectiva and successfully integrated Objectiva into our financial reporting process. We believe that this acquisition did not result in a significant change in our internal controls over financial reporting, nor were there any other changes in internal controls over financial reporting or in other factors that materially affected, or are reasonably likely to materially affect, controls over financial reporting, nor were there any other corrective actions required with regard to significant deficiencies and material weaknesses.

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

We are not involved in any material legal proceedings.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

On July 20, 2004, we completed the acquisition of the remaining 79% of the outstanding common stock of Objectiva, which upon completion of the acquisition became our wholly-owned subsidiary. The acquisition was consummated pursuant to that certain Stock Purchase Agreement, dated as of June 27, 2004, by and among Document Sciences and the selling stockholders identified therein, in which we paid consideration of $3,609,827, consisting of $392,844 in cash and 629,793 shares of our common stock (with a value of $3,216,983 calculated based on the average price per share of common stock as of the close of trading from July 16 through July 22, 2004).

 

The stock consideration issued in the acquisition from our authorized but unissued shares of common stock and was exempt from registration pursuant to Section 4(2) of the Securities Act of 1933, as amended, as the transaction did not involve a public offering.

 

The following table provides information about purchases of equity securities by us or affiliated purchases during the quarter ended September 30, 2004:

 

Period


  

Total Number

of Shares

Purchased


   

Average Price

Paid per Share


   Total Number of Shares
Purchased as Part of
Publicly Announced Plan


  

Maximum Number of
Shares that May Yet

Be Purchased Under

the Plan


July

   —         —      —      —  

August

   9,862 (a)   $ 4.82    —      —  

September

   —         —      —      —  

(a) These shares of our common stock were repurchased in privately negotiated transactions.

 

ITEM 6. EXHIBITS

 

Exhibit
Number


  

Exhibit Description


3.1    (1)    Amended and Restated Certificate of Incorporation.
3.2    (1)    Amended and Restated Bylaws.
4.1    (2)    Specimen Stock Certificate.
4.2    (3)    Rights Agreement between the Registrant and U.S. Stock Transfer Corporation, as Rights Agent, dated May 11, 2001, which includes as Exhibit A thereto the form of Rights Certificate to be Distributed to Holders of Rights after the Distribution Date (as that term is defined in the Rights Agreement).

 

25


Table of Contents
10.1    (2, #)    Form of Indemnity Agreement Between the Registrant and each of its Officers and Directors.
10.2    (3)    Form of Software License and Software Support Agreement.
10.3    (3)    Form of Professional Services Agreement.
10.4    (3)    Form of Value Added Reseller Agreement.
10.5    (4, #)    1997 Employee Stock Purchase Plan, as Amended.
10.6    (4)    Lease for Principal Facilities, as Amended, and Assignment of Lease.
10.7    (5, #)    John L. McGannon Employment Agreement.
10.8    (6)    Stock Repurchase Agreement Between Xerox and the Registrant.
10.9    (7)    Development Services and Referral Agreement Between Objectiva Software Solutions, Inc. and the Registrant dated January 16, 2004.
10.10  (8)    2004 Stock Incentive Plan.
10.11  (#,*)    Form of Stock Option Agreement Used in Connection with the Registrant’s 2004 Stock Incentive Plan.
10.12  (9)    Stock Purchase Agreement Between Objectiva Software Solutions, Inc. and the Registrant.
10.13  (10, #)    Tao Ye Employment Agreement.
10.14  (10, #)    Nasser Barghouti Employment Agreement.
10.15  (10, #)    J. Douglas Winter Employment Agreement.
14.1    (7)    Code of Conduct.
31       (*)    Certification of CEO/CFO Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32       (*)    Certification of CEO/CFO Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

(1) Previously filed as an exhibit to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 20, 2004.
(2) Previously filed as exhibits to Registration Statement on Form S-1 Registration Number 333-06344.
(3) Previously filed as exhibits to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2001.
(4) Previously filed as exhibits to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 1998.
(5) Previously filed as exhibits to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2000.
(6) Previously filed as an exhibit to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on November 20, 2003.
(7) Previously filed as exhibits to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2003.
(8) Previously filed as Appendix A to the Registrant’s Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on March 29, 2004.
(9) Previously filed as an exhibit to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on August 4, 2004.
(10) Previously filed as exhibits to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2004.
(#) Indicates management compensatory plan, contract or arrangement.
(*) Filed herewith.

 

26


Table of Contents

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    DOCUMENT SCIENCES CORPORATION
Date: November 15, 2004  

/s/ John L. McGannon


    John L. McGannon
    President, Chief Executive Officer and
    Chief Financial Officer
    (Principal Executive Officer and
    Principal Financial Officer)

 

27


Table of Contents

EXHIBIT INDEX

 

Exhibit
Number


  

Exhibit Description


   Page

3.1    (1)    Amended and Restated Certificate of Incorporation.     
3.2    (1)    Amended and Restated Bylaws.     
4.1    (2)    Specimen Stock Certificate.     
4.2    (3)    Rights Agreement between the Registrant and U.S. Stock Transfer Corporation, as Rights Agent, dated May 11, 2001, which includes as Exhibit A thereto the form of Rights Certificate to be Distributed to Holders of Rights after the Distribution Date (as that term is defined in the Rights Agreement).     
10.1    (2, #)    Form of Indemnity Agreement Between the Registrant and each of its Officers and Directors.     
10.2    (3)    Form of Software License and Software Support Agreement.     
10.3    (3)    Form of Professional Services Agreement.     
10.4    (3)    Form of Value Added Reseller Agreement.     
10.5    (4, #)    1997 Employee Stock Purchase Plan, as Amended.     
10.6    (4)    Lease for Principal Facilities, as Amended, and Assignment of Lease.     
10.7    (5, #)    John L. McGannon Employment Agreement.     
10.8    (6)    Stock Repurchase Agreement Between Xerox and the Registrant.     
10.9    (7)    Development Services and Referral Agreement Between Objectiva Software Solutions, Inc. and the Registrant dated January 16, 2004.     
10.10  (8)    2004 Stock Incentive Plan.     
10.11  (#,*)    Form of Stock Option Agreement Used in Connection with the Registrant’s 2004 Stock Incentive Plan.     
10.12  (9)    Stock Purchase Agreement Between Objectiva Software Solutions, Inc. and the Registrant.     
10.13  (10, #)    Tao Ye Employment Agreement.     
10.14  (10, #)    Nasser Barghouti Employment Agreement.     
10.15  (10, #)    J. Douglas Winter Employment Agreement.     
14.1    (7)    Code of Conduct.     
31       (*)    Certification of CEO/CFO Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.     
32       (*)    Certification of CEO/CFO Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.     

(1) Previously filed as an exhibit to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 20, 2004.
(2) Previously filed as exhibits to Registration Statement on Form S-1 Registration Number 333-06344.
(3) Previously filed as exhibits to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2001.
(4) Previously filed as exhibits to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 1998.
(5) Previously filed as exhibits to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2000.
(6) Previously filed as an exhibit to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on November 20, 2003.
(7) Previously filed as exhibits to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2003.
(8) Previously filed as Appendix A to the Registrant’s Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on March 29, 2004.
(9) Previously filed as an exhibit to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on August 4, 2004.
(10) Previously filed as exhibits to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2004.
(#) Indicates management compensatory plan, contract or arrangement.
(*) Filed herewith.

 

28